Published Date:2021-06-03 Original Link:https://www.onenessbio.com/en/news_detail45_3.htm No 1 Date of announcement 2021/06/03 Time of announcement 18:48:46 Subject The Phase 3 international MRCT study results of the diabetic foot ulcer new drug, Fespixon have been accepted for oral presentation at the 57th EASD Annual Meeting      To which item it meets paragraph 12 Date of events 2021/06/03...Read More